Arthur T. Sands
Overview
Arthur T. Sands received an average of $7M in total compensation, including $539K in salary, at Nurix Therapeutics from 2019 to 2023. Arthur Sands also received an average of $2M at Lexicon Pharmaceuticals from 2006 to 2014.
- 2023
- 2022
- 2021
- 2020
- 2019
- 2014
- 2013
- 2012
- 2011
- 2010
Nurix TherapeuticsPresident, Chief Executive Officer and Director
Nurix TherapeuticsPresident, Chief Executive Officer and Director
Nurix TherapeuticsPresident, Chief Executive Officer and Director
Nurix TherapeuticsPresident, Chief Executive Officer and Director
Nurix TherapeuticsPresident, Chief Executive Officer and Director
Lexicon PharmaceuticalsFormer President, Chief Executive Officer and Director
Lexicon PharmaceuticalsFormer President, Chief Executive Officer and Director
Lexicon PharmaceuticalsFormer President, Chief Executive Officer and Director
Lexicon PharmaceuticalsPresident, Chief Executive Officer and Director
Lexicon PharmaceuticalsPresident, Chief Executive Officer and Director
Related executives
We found 19 more executives who work or worked at Nurix Therapeutics and Lexicon Pharmaceuticals.
Lonnel Coats
Lexicon Pharmaceuticals
Chief Executive Officer
Jeffrey Wade
Lexicon Pharmaceuticals
Chief Financial Officer
Gwenn Hansen
Nurix Therapeutics
Chief Scientific Officer
Hans van Houte
Nurix Therapeutics
Chief Financial Officer
Craig Granowitz
Lexicon Pharmaceuticals
Chief Medical Officer
Brian Crum
Lexicon Pharmaceuticals
General Counsel
Alan Main
Lexicon Pharmaceuticals
Executive Vice President, Innovation and Chemical Sciences
Stefani Wolff
Nurix Therapeutics
Chief Operating Officer
News
Nurix Therapeutics CEO Arthur Sands' 2023 pay falls 54% to $4.4M
March 27, 2024
Nurix Therapeutics CEO Arthur Sands' 2022 pay jumps 97% to $9.4M
March 24, 2023
Nurix Therapeutics COO Stefani Wolff receives $7.1M in 2021
March 25, 2022
Nurix Therapeutics CEO Arthur Sands' 2020 pay jumps 1,041% to $17M
March 25, 2021